Renova Therapeutics
Carlsbad · Founded 2009
About Renova Therapeutics
Renova Therapeutics provides gene therapy pursuing the development of treatments for congestive heart failure and chronic diseases. They enable the generation of an original platform of therapeutics and delivery systems that in a dose may provide treatments for chronic diseases including congestive heart failure and diabetes. Their investigational gene therapies are based on validated and proprietary research into disease mechanisms.
Company Facts
- Founded: 2009
- Legal name: Renova Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $7.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2017)
- Website: renovatherapeutics.com
- Phone: +1 858 461 1837
Social Profiles
Canonical: https://fsome.com/organization/renova-therapeutics-8396603 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.